tirzepatide kidney Renal effects of GLP-1 receptor agonists and in individuals with type 2 diabetes: seeds of a promising future | Endocrine Tirzepatide and Kidney Health: Safety

Reddit did not immediately respond to Forbes request for comment

Managing side effects during dose increases Gastrointestinal side effects such as nausea, vomiting, and diarrhea are common while taking GLP-1 medication and usually appear during the start of the medication or when the dose is increased

Do consider escalation when appetite has returned, adherence is solid, nutrition is adequate, side effects are tolerable, and metabolic goals are not being met

This baseline becomes essential for distinguishing hypothyroid symptoms from GLP-1 side effects

Tirzepatide, a dual GIP/GLP1 receptor coagonist unprecedented effectiveness regarding glycaemic control and body weight reduction